What Sets Us Apart
Chronic myelogenous leukemia is a slow-growing cancer that starts in the bone marrow, the spongy tissue inside bones, and spreads to the blood. People with this condition have a translocation, or the movement of part of one gene on one chromosome to another. This creates a fusion gene that produces too many immature white blood cells in the bone marrow and the blood. Eventually, these leukemia cells crowd out healthy cells so that the body cannot function normally.
Though chronic myelogenous leukemia is a chronic cancer, targeted treatments have helped many people achieve long-term remission, in which cancer cells are no longer detected in the body. Specialists at NYU Langone’s Laura and Isaac Perlmutter Cancer Center offer effective targeted therapies, coupled with psychosocial support, to help people thrive during treatment for the condition.
Doctors at NYU Langone also diagnose and treat childhood leukemias.
Treatment at NYU Langone
Treatment of chronic myelogenous leukemia typically includes targeted chemotherapy drugs, which cause leukemia cells to stop growing and die. Often, this is the only treatment required. If you have a more aggressive cancer, your doctor may recommend a stem cell transplant.